From: A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors
Marker | HGSC (n = 114) | LGSC (n = 97) | mSBT (n = 39) | HGSC vs. (LGSC + mSBT) p-value | HGSC vs. LGSC p-value | LGSC vs. mSBTp-value |
---|---|---|---|---|---|---|
ER | < 0.001 | 0.004 | 1.000 | |||
n positive | 101 (89%) | 93 (99%) | 39 (100%) | |||
n negative | 13 (11%) | 1 (1%) | 0 (0%) | |||
PR | < 0.001 | 0.005 | < 0.001 | |||
n positive | 36 (32%) | 49 (51%) | 32 (82%) | |||
n negative | 78 (68%) | 48 (49%) | 7 (18%) | |||
PAX8 | 1.000 | 1.000 | 1.000 | |||
n positive | 113 (99%) | 95 (99%) | 39 (100%) | |||
n negative | 1 (1%) | 1 (1%) | 0 (0%) | |||
ARID1A | 0.068 | 0.082 | 1.000 | |||
n positive | 112 (98%) | 88 (93%) | 36 (95%) | |||
n negative | 2 (2%) | 7 (7%) | 2 (5%) | |||
PTEN | < 0.001 | < 0.001 | 1.000 | |||
n positive | 96 (84%) | 95 (99%) | 38 (100%) | |||
n negative | 18 (16%) | 1 (1%) | 0 (0%) | |||
HNF1B | 0.801 | 0.538 | 0.294 | |||
n positive | 34 (30%) | 24 (26%) | 12 (35%) | |||
n negative | 80 (70%) | 69 (74%) | 22 (65%) | |||
Napsin A | NULL | NULL | NULL | |||
n positive | 0 (0%) | 0 (0%) | 0 (0%) | |||
n negative | 114 (100%) | 96 (100%) | 39 (100%) | |||
CDX2 | 0.334 | 0.626 | 1.000 | |||
n positive | 3 (3%) | 1 (1%) | 0 (0%) | |||
n negative | 111 (97%) | 96 (99%) | 39 (100%) | |||
NTRK | 0.458 | 1.000 | NULL | |||
n positive | 1 (1%) | 0 (0%) | 0 (0%) | |||
n negative | 113 (99%) | 96 (100%) | 39 (100%) | |||
MUC4 | 0.181 | 0.377 | 1.000 | |||
n positive | 4 (4%) | 1 (1%) | 0 (0%) | |||
n negative | 110 (96%) | 96 (99%) | 39 (100%) | |||
BRG1 | 1.000 | 0.459 | 1.000 | |||
n positive | 114 (100%) | 96 (99%) | 39 (100%) | |||
n negative | 0 (0%) | 1 (1%) | 0 (0%) | |||
PAX2 | < 0.001 | < 0.001 | 0.118 | |||
n positive | 47 (41%) | 64 (67%) | 30 (81%) | |||
n negative | 67 (59%) | 31 (33%) | 7 (19%) | |||
Mammaglobin | 0.009 | 0.002 | 0.050 | |||
n positive | 16 (14%) | 2 (2%) | 4 (11%) | |||
n negative | 98 (86%) | 94 (98%) | 33 (89%) | |||
SATB2 | 0.475 | 0.728 | 0.557 | |||
n positive | 5 (4%) | 3 (3%) | 0 (0%) | |||
n negative | 109 (96%) | 94 (97%) | 39 (100%) | |||
RB1 | < 0.001 | 0.002 | 1.000 | |||
n positive | 97 (86%) | 90 (98%) | 39 (100%) | |||
n negative | 16 (14%) | 2 (2%) | 0 (0%) | |||
AMACR | 0.588 | 0.461 | 0.508 | |||
n positive | 8 (7%) | 10 (10%) | 2 (5%) | |||
n negative | 106 (93%) | 86 (90%) | 37 (95%) | |||
TTF1 | 0.456 | 1.000 | NULL | |||
n positive | 1 (1%) | 0 (0%) | 0 (0%) | |||
n negative | 113 (99%) | 97 (100%) | 39 (100%) | |||
Cyclin E1 | < 0.001 | < 0.001 | 0.743 | |||
n positive | 108 (95%) | 68 (73%) | 26 (70%) | |||
n negative | 6 (5%) | 25 (27%) | 11 (30%) | |||
Statmin | < 0.001 | < 0.001 | 0.431 | |||
n positive | 110 (96%) | 66 (70%) | 24 (63%) | |||
n negative | 4 (4%) | 28 (30%) | 14 (37%) | |||
BCOR | NULL | NULL | NULL | |||
n positive | 0 (0%) | 0 (0%) | 0 (0%) | |||
n negative | 114 (100%) | 97 (100%) | 39 (100%) | |||
L1CAM | 0.002 | 0.045 | 0.037 | |||
n positive | 39 (34%) | 20 (21%) | 2 (5%) | |||
n negative | 75 (66%) | 75 (79%) | 35 (95%) | |||
LMP2 | 0.002 | 0.009 | NULL | |||
n positive | 106 (93%) | 95 (100%) | 38 (100%) | |||
n negative | 8 (7%) | 0 (0%) | 0 (0%) | |||
CD44 | < 0.001 | < 0.001 | 1.000 | |||
n positive | 30 (26%) | 3 (3%) | 1 (3%) | |||
n negative | 84 (74%) | 90 (97%) | 36 (97%) | |||
Ki67 | < 0.001 | < 0.001 | 0.573 | |||
n positive | 109 (96%) | 16 (18%) | 5 (14%) | |||
n negative | 5 (4%) | 75 (82%) | 32 (86%) | |||
p16a | < 0.001 | < 0.001 | NULL | |||
n positive | 77 (68%) | 0 (0%) | 0 (0%) | |||
n negative | 37 (32%) | 96 (100%) | 38 (100%) | |||
p53a | < 0.001 | < 0.001 | NULL | |||
n positive | 98 (91%) | 0 (0%) | 0 (0%) | |||
n negative | 10 (9%) | 96 (100%) | 38 (100%) |